Search

Adam Hoye Phones & Addresses

  • 117 Upland Ter, Bala Cynwyd, PA 19004
  • Philadelphia, PA
  • 250 Melwood Ave, Pittsburgh, PA 15213 (412) 688-0333
  • 4609 Bayard St, Pittsburgh, PA 15213 (412) 688-0333
  • Saint Paul, MN

Work

Company: Avid radiopharmaceuticals Feb 2018 Position: Principal research scientist

Education

Degree: Doctorates, Doctor of Philosophy School / High School: University of Pittsburgh 2004 to 2010 Specialities: Philosophy, Organic Chemistry

Skills

Organic Synthesis • Nmr • Organic Chemistry • Medicinal Chemistry • Chemistry • Drug Discovery • Mass Spectrometry • Lc Ms • Nmr Spectroscopy • Hplc • Chromatography • Purification • Spectroscopy

Industries

Pharmaceuticals

Resumes

Resumes

Adam Hoye Photo 1

Principal Research Scientist

View page
Location:
3711 Market St, Philadelphia, PA 19104
Industry:
Pharmaceuticals
Work:
Avid Radiopharmaceuticals
Principal Research Scientist

Avid Radiopharmaceuticals
Senior Research Chemist

Avid Radiopharmaceuticals Oct 2012 - Jul 2015
Research Chemist

University of Pennsylvania Oct 2010 - Oct 2012
Postdoctoral Associate
Education:
University of Pittsburgh 2004 - 2010
Doctorates, Doctor of Philosophy, Philosophy, Organic Chemistry
Grinnell College 2000 - 2004
Bachelors, Bachelor of Arts, Chemistry
Skills:
Organic Synthesis
Nmr
Organic Chemistry
Medicinal Chemistry
Chemistry
Drug Discovery
Mass Spectrometry
Lc Ms
Nmr Spectroscopy
Hplc
Chromatography
Purification
Spectroscopy

Publications

Us Patents

Heterocyclic Compounds And Their Use For The Treatment Of Neurodegenerative Tauopathies

View page
US Patent:
20150224105, Aug 13, 2015
Filed:
Sep 19, 2013
Appl. No.:
14/429101
Inventors:
- Philadelphia, PA, US
Kurt R. Brunden - Media PA, US
Adam T. Hoye - Philadelphia PA, US
Virginia M.Y. Lee - Philadelphia PA, US
Amos B. Smith - Merion PA, US
John Q. Trojanowski - Philadelphia PA, US
International Classification:
A61K 31/5377
A61K 31/519
A61K 31/501
A61K 31/4985
A61K 31/53
A61K 31/506
A61K 31/50
Abstract:
The present invention is directed to triazolopyrimidine, phenylpyrimidine, pyridopyridazine, and pyridotriazine compounds which are microtubule-stabilizing compounds and their use in the treatment of neurodegenerative disorders, in particular, tauopathies, such as for example, Alzheimer's disease, frontotemporal lobar degeneration, Pick's disease, progressive supranuclear palsy (PSP), and corticobasal degeneration. In addition, the compounds of the invention may be useful for other diseases where tau pathology is a comorbidity or where microtubule function is compromised, for example, schizophrenia, Parkinson's disease (PD), PD with dementia, Lewy body disease with dementia, and amyotrophic lateral sclerosis.
Adam T Hoye from Bala Cynwyd, PA, age ~43 Get Report